Shineco, Inc.

As of November 14, 2023, Shineco, Inc. is rated as risky and overvalued, with poor financial metrics including a P/E ratio of -15.76 and a year-to-date return of -96.68%, significantly underperforming the S&P 500's 12.22% return.

As of November 14, 2023, Shineco, Inc. is rated as risky and overvalued due to significant financial distress, with key ratios indicating poor performance compared to peers and a year-to-date return of -95.08% against the S&P 500's 2.44%.

As of June 13, 2025, Shineco, Inc. is in a bearish trend with moderate strength, supported by daily moving averages, KST, Dow Theory, and Bollinger Bands, despite some mildly bullish signals from the MACD.

As of March 2022, the management team of Shineco, Inc. includes Chairman Mr. Yuying Zhang, CFO Mr. Sam Wang, Directors Mr. Jiping Chen, Mr. Ning Chen, Mr. Baolin Li, and Independent Directors Mr. Yanzeng An and Mr. Harry Edelson. They oversee the company's strategic direction and financial management.

Shineco, Inc. is a holding company focused on health and well-being plant-based products in the Other Agricultural Products industry, with a market cap of $6.64 million and recent net sales of $0 million. As of March 2025, it reported a net profit loss of $4 million.

As of Jun 24, Shineco, Inc. has a market capitalization of 6.64 million, with net sales of 9.75 million and a net profit loss of 29.20 million over the latest four quarters. The company has shareholder's funds of 26.00 million and total assets of 84.61 million.